AMN Healthcare Services has rallied strongly this year, which puts fresh attention on whether the underlying cash generation can carry the current share price. With the stock now trading far above where it started the year, the question is how well its future cash flows line up with what the market is paying today.
- The share price is up 134.4% year to date, which places significant focus on whether AMN Healthcare Services can continue turning its operations into solid cash flow.
- The business is influenced by staffing volumes, pricing and cost control, so any change in demand from healthcare providers or in wage pressures may feed directly into the level and timing of cash it can produce for shareholders.
- What if you looked at AMN Healthcare Services through its earnings instead? See why AMN Healthcare Services's 13.1x P/E tells a different valuation story.
The stock's next move may depend on whether the current valuation is well supported by the cash flows that AMN Healthcare Services is expected to generate over time.
If you want more ideas built around cash generation rather than share price swings, a focused starting point is a screen of 26 high quality undervalued stocks.
Is AMN Healthcare Services Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model used here focuses on the cash AMN Healthcare Services can produce for shareholders over time and then discounts it back to today. On the latest numbers, the company generated trailing twelve month free cash flow of about $399.6 million, which the model then fades down to an estimated $117.9 million by 2027 and lower levels beyond that. That profile points to a business where recent cash generation looks strong in dollar terms, while the projection set assumes more muted cash in future years rather than aggressive expansion.
When those projected cash streams are discounted using this approach, the resulting intrinsic value is calculated as meaningfully above the current share price of $35.44. For anyone tracking AMN Healthcare Services after its strong share price move, the key takeaway is that the current DCF still treats recent free cash flow as relatively high compared with what is pencilled in several years out, yet the present market price sits below the value implied by those estimates. Find out what AMN Healthcare Services could be worth using our Discounted Cash Flow (DCF) estimate.
The AMN Healthcare Services Narrative: What Would Justify Today's Price?
Narratives for AMN Healthcare Services sit between the DCF output and the share price and describe which paths for growth, profitability and earnings would need to hold for the stock to be worth materially more or less than today’s level on Simply Wall St's Community page. Rather than relying on a single valuation multiple or model line, each narrative lays out its own set of drivers and assumptions so you can compare them with actual results as they are reported.
Community narratives on AMN Healthcare Services split between those who see grounded upside in the model and those who think recovery hopes run ahead of the fundamentals.
Bull case: roughly fairly valued
"AMN's continued rollout of technology driven solutions, including AI enabled talent platforms, process automation that shortened recruiter cycle times during recent strike work, and the expanding Passport app user base that reached more than 400,000 clinicians, is starting to reshape how the company sources and matches workers..."
Discover why this Narrative puts AMN Healthcare Services at roughly fairly valued.
Bear case: 33% overvalued
"Demand softness in core staffing offerings and heightened pricing competition may limit revenue and margin improvement in the near term..."
Explore why this Narrative puts AMN Healthcare Services at 33% overvalued.
One more AMN Healthcare Services check before you stop at the share price
Before you park the calculator, it is worth asking who is steering AMN Healthcare Services, how they are rewarded, and whether those incentives run alongside your interests. See who runs AMN Healthcare Services and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com